F. Lamers-Karnebeek
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 11
- Systemic Lupus Erythematosus Research 5
- Spondyloarthritis Studies and Treatments 3
- Osteoarthritis Treatment and Mechanisms 2
-
- COVID-19 Clinical Research Studies 3
-
- Lymphoma Diagnosis and Treatment 2
- Systemic Sclerosis and Related Diseases 2
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Tim JansenPiet L. C. M. van RielJolanda J. LuimeJohannes W. G. JacobsT. Martijn KuijperJohanna M W HazesArtur BachtaGeorge A. W. Bruyn
- Cited by
- RheumatologyHematologyNephrology
- Journals
- PLoS ONE (1 paper)Annals of the Rheumatic Diseases (6 papers)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- NetherlandsUnited StatesNorway
In The Last Decade
F. Lamers-Karnebeek
15 papers receiving 260 citations
Peers
Comparison fields: 5 of 51
- Rheumatology 215
- Hematology 56
- Nephrology 33
- Genetics 32
- Immunology 43
Countries citing papers authored by F. Lamers-Karnebeek
This map shows the geographic impact of F. Lamers-Karnebeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lamers-Karnebeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lamers-Karnebeek more than expected).
Fields of papers citing papers by F. Lamers-Karnebeek
This network shows the impact of papers produced by F. Lamers-Karnebeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lamers-Karnebeek. The network helps show where F. Lamers-Karnebeek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. Lamers-Karnebeek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 0 | |
| 4 | 2019 | 4 | |
| 5 | 2019 | 2 | |
| 6 | 2018 | 18 | |
| 7 | 2018 | 11 | |
| 8 | 2017 | 15 | |
| 9 | 2016 | 1 | |
| 10 | 2015 | 73 | |
| 11 | 2015 | 70 | |
| 12 | 2015 | 4 | |
| 13 | 2015 | 14 | |
| 14 | 2014 | 7 | |
| 15 | 2014 | 38 | |
| 16 | 2013 | 4 |
About F. Lamers-Karnebeek
F. Lamers-Karnebeek is a scholar working on Rheumatology, Dermatology and Pathology and Forensic Medicine, having authored 16 papers that have together received 263 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (11 papers), Systemic Lupus Erythematosus Research (5 papers), Spondyloarthritis Studies and Treatments (3 papers), COVID-19 Clinical Research Studies (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Systemic Sclerosis and Related Diseases (2 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Rheumatology (215 citations), Hematology (56 citations) and Nephrology (33 citations). F. Lamers-Karnebeek has collaborated with scholars based in Netherlands, United States and Norway. Frequent co-authors include Tim Jansen, Piet L. C. M. van Riel, Jolanda J. Luime, Johannes W. G. Jacobs, T. Martijn Kuijper, Johanna M W Hazes, Artur Bachta, George A. W. Bruyn, Maria Antonietta D’Agostino and Hilde Berner Hammer. Their work appears in journals such as PLoS ONE, Annals of the Rheumatic Diseases and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.